The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.

Mazzola, E., Bruccoleri, M., Perrone, G. (2016). Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 70(2-3), 109-134 [10.1504/IJTM.2016.075152].

Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry

MAZZOLA, Erica;BRUCCOLERI, Manfredi;PERRONE, Giovanni
2016-01-01

Abstract

The research presented in this paper explores the effect of inbound, outbound and coupled open innovation practices on firms' performances in the biopharmaceutical industry. Specifically, although existing researches on open innovation effectiveness have separately investigated the effect of open innovation practices on innovation and financial performance, this study evaluates the concurrent effect of these practices on both such performance dimensions in a single framework. We state the importance for a manager to explore concurrently the influence of specific open innovation practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on the NASDAQ biotechnology index.
2016
Mazzola, E., Bruccoleri, M., Perrone, G. (2016). Open innovation and firms' performance: State of the art and empirical evidences from the bio-pharmaceutical industry. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 70(2-3), 109-134 [10.1504/IJTM.2016.075152].
File in questo prodotto:
File Dimensione Formato  
Mazzola et al., 2016_IJTM.pdf

accesso aperto

Dimensione 308.72 kB
Formato Adobe PDF
308.72 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/213435
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 35
social impact